Companies
Daxiang Biotech
Daxiang Biotech develops industrial OoC platforms made of biocompatible plastics replacing PDMS to prevent the absorption of small hydrophobic drug molecules.
- Country
- China
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Raised over CNY 300 million in total funding across multiple rounds (Angel, Series A, and Series B) | caplight.com · daxiangbio.cn · daxiangbio.com · preqin.com |
| Capacity | Operates a closed loop that spans platform design, research execution, and industrial production; capacity includes 50+ culture kits and 100+ biomimetic models medium confidence | daxiangbio.cn · lifesciencesreview.com |
| Certification | GB/T19001-2016/ISO9001:2015 quality management system certification (2022) | daxiangbio.cn |
| Regulatory approval | Supports pharmaceutical firms in IND clearances; models have passed authoritative third-party technical verification, including successful predictions for kidney, intestine, and liver chips | daxiangbio.cn · lifesciencesreview.com |
| Production site | Beijing, China (Yiyuan Industrial Base, Haidian District) | daxiangbio.com · daxiangbio.cn · lifesciencesreview.com |
| Headcount | Reports of 1 to 4 employees in some professional database listings, though the company describes itself as a leading industrial firm with a complete operational structure medium confidence | caplight.com |
Independent sources: caplight.com · lifesciencesreview.com · preqin.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Organoids & organ-on-chip | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.